_256_384.jpg)
In Q2FY22, growth from Covid-driven products in the domestic branded formulation sales should dissipate on a QoQ basis as new covid cases have declined sharply. Vishal Manchanda, research analyst Nirmal Bang gives a preview of pharma companies in this report
This product will be manufactured at Lupin’s Pithampur facility In India
A growing number of studies have shown the benefit of a third dose of Covid-19 vaccine in immunocompromised subjects
The rates for over 400 procedures were revised
The company will use the capital for building its team, product development, marketing, and setting up in-school clinics to deliver connected health to one million families
The transaction is anticipated to close in the first quarter of 2022
A total of 8308 stores are open across India and medicines are priced at affordable rates
The initiative will create an integrated network of Critical Care Units (CCUs) across the Apollo Hospitals network but also in partnership with non-Apollo units in India and overseas
The company claims to be a market leader in core orthopaedic and gynaecology segments like bone and joint disorders, pain management and, pregnancy and women’s nutrition
This is the first time in South Asia an indigenously made drone was used to transport Covid-19 vaccines
Subscribe To Our Newsletter & Stay Updated
